LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged sipo · clear

USPTO Policy

Experts Void From U S Patent Train Wreck Is Being Filled by China S Patent System

In a few short years China’s patent system has gone from an IP rights wannabe to one of the most responsive and patent-friendly systems in the world. Leading U.S. IP experts say that underlying this rapid evolution is a desire for China to become a…

January 30, 2017·USPTO Policy·5 min read
USPTO Policy

Innovation in China

In 2012, Chinese inventors filed more patent applications than those in any other country--including the United States. In a recent Booz & Company report (Ed: now Strategy&) , the authors surveyed many major Chinese and multinational companies to explore…

January 14, 2013·USPTO Policy·3 min read
Trademark

China S Shift From Imitation to Innovation

The United States has always been a leader when it comes to innovation and invention. However, the United States Patent and Trademark Office (USPTO) has become overworked and backlogged in recent years, resulting in a slow patent approval system and the…

May 23, 2012·Trademark·4 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.